CLINICAL_TRIALS trial_result · 2021-09-29

Clinical Trial Update: Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients [Phase 2]

Phase 2 trial assessing efficacy and safety of WTX101 (ALXN1840) in adults with Wilson disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Wilson Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-09-29